Details for Patent: 9,333,270
✉ Email this page to a colleague
Which drugs does patent 9,333,270 protect, and when does it expire?
Patent 9,333,270 protects CYTALUX and is included in one NDA.
This patent has thirty-five patent family members in twelve countries.
Summary for Patent: 9,333,270
Title: | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors |
Abstract: | The present disclosure relates to compounds that are useful as near-infrared fluorescence probes, wherein the compounds include i) a pteroyl ligand that binds to a target receptor protein, ii) a dye molecule, and iii) a linker molecule that comprises an amino acid or derivative thereof. The disclosure further describes methods and compositions for making and using the compounds, methods incorporating the compounds, and kits incorporating the compounds. |
Inventor(s): | Low; Philip S. (West Lafayette, IN), Kularatne; Sumith A. (West Lafayette, IN), Mahalingam; Sakkarapalayam M. (West Lafayette, IN) |
Assignee: | Purdue Research Foundation (West Lafayette, IN) |
Application Number: | 14/010,098 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,333,270
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
On Target Labs | CYTALUX | pafolacianine sodium | SOLUTION;INTRAVENOUS | 214907-001 | Nov 29, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | CYTALUX IS AN OPTICAL IMAGING AGENT INDICATED IN ADULT PATIENTS WITH OVARIAN CANCER AS AN ADJUNCT FOR INTRAOPERATIVE IDENTIFICATION OF MALIGNANT LESIONS | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,333,270
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013381391 | ⤷ Try a Trial | |||
Australia | 2013383382 | ⤷ Try a Trial | |||
Australia | 2013383386 | ⤷ Try a Trial | |||
Australia | 2017203340 | ⤷ Try a Trial | |||
Brazil | 112015022810 | ⤷ Try a Trial | |||
Canada | 2902205 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |